Nonlinear pharmacokinetics of rituximab in non‐Hodgkin lymphomas: A pilot study

AIMS: Rituximab is an anti‐CD20 monoclonal antibody approved in non‐Hodgkin lymphoma (NHL). This study aimed to assess the relationship between antigen mass and nonlinear pharmacokinetics of rituximab in NHL patients. METHODS: In a retrospective cohort of 25 NHL patients treated with rituximab, anti...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Br J Clin Pharmacol
Main Authors: Ternant, David, Monjanel, Hélène, Venel, Yann, Prunier‐Aesch, Caroline, Arbion, Flavie, Colombat, Philippe, Paintaud, Gilles, Gyan, Emmanuel
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley and Sons Inc. 2019
Fag:
Original Articles
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6710546/
https://ncbi.nlm.nih.gov/pubmed/31112622
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.13991
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker